Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-02

Clinical Trial Update: Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating phenytoin for prophylaxis of seizures in patients with pneumococcal meningitis aged 50 and older; study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenytoin (Phenytoin)

Snippet

Sponsor: M. Carmen Cabellos Minguez | Conditions: Seizures, Pneumococcal Meningitis | Phase 4 | Status: TERMINATED